David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$986M |
| 2 |
Sea Limited
SE
|
+$480M |
| 3 |
Snowflake
SNOW
|
+$441M |
| 4 |
Citigroup
C
|
+$422M |
| 5 |
Oracle
ORCL
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$575M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Mastercard
MA
|
+$506M |
| 4 |
Walt Disney
DIS
|
+$447M |
| 5 |
Alibaba
BABA
|
+$434M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.89% |
| 2 | Technology | 13.97% |
| 3 | Consumer Discretionary | 9.19% |
| 4 | Financials | 7.48% |
| 5 | Healthcare | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Zoetis
ZTS
$32B
| $2.44M | ﹤0.01% |
10,000
| – | – |
|
|
HUGS
3027
DELISTED
USHG Acquisition Corp.
HUGS
| $2.44M | ﹤0.01% |
235,149
+63,771
| +37% | +$645K |
|
3028
Ovid Therapeutics
OVID
$547M
| $2.44M | ﹤0.01% |
759,096
+30,166
| +4% | +$103K |
|
3029
PUT
Protolabs
PRLB
$1.91B
| $2.43M | ﹤0.01% |
47,300
-3,500
| -7% | -$207K |
|
3030
PUT
Coursera
COUR
$1.71B
| $2.42M | ﹤0.01% |
+99,200
| New | +$3.02M |
|
3031
PUT
DuPont de Nemours
DD
$18.5B
| $2.42M | ﹤0.01% |
23,900
| – | – |
|
|
ACB
3032
PUT
Aurora Cannabis
ACB
$254M
| $2.42M | ﹤0.01% |
44,730
| – | – |
|
|
DOC
3033
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.42M | ﹤0.01% |
128,540
+77,042
| +150% | +$1.42M |
|
3034
ESCO Technologies
ESE
$7.18B
| $2.42M | ﹤0.01% |
26,849
-20,493
| -43% | -$1.77M |
|
3035
CALL
KE Holdings
BEKE
$20.2B
| $2.41M | ﹤0.01% |
120,000
| – | – |
|
|
VTLE
3036
PUT
DELISTED
Vital Energy
VTLE
| $2.4M | ﹤0.01% |
40,000
+10,000
| +33% | +$706K |
|
|
IACC
3037
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
| $2.4M | ﹤0.01% |
245,868
-397
| -0.2% | -$3.88K |
|
3038
Medifast
MED
$136M
| $2.4M | ﹤0.01% |
+11,474
| New | +$2.37M |
|
3039
CALL
Biogen
BIIB
$32.3B
| $2.4M | ﹤0.01% |
+10,000
| New | +$2.57M |
|
3040
Fresenius Medical Care
FMS
$12.3B
| $2.4M | ﹤0.01% |
+73,880
| New | +$2.43M |
|
|
WINV
3041
DELISTED
WinVest Acquisition Corp. Common Stock
WINV
| $2.39M | ﹤0.01% |
+243,000
| New | +$2.39M |
|
|
GIAC
3042
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
| $2.39M | ﹤0.01% |
+243,793
| New | +$2.39M |
|
3043
PUT
Ciena
CIEN
$53.6B
| $2.39M | ﹤0.01% |
31,000
+1,000
| +3% | +$61.7K |
|
3044
SunCar Technology Group
SDA
$70.5M
| $2.38M | ﹤0.01% |
239,460
+59,609
| +33% | +$591K |
|
3045
ScottsMiracle-Gro
SMG
$3.52B
| $2.38M | ﹤0.01% |
14,784
-119,677
| -89% | -$18.5M |
|
3046
Ginkgo Bioworks
DNA
$469M
| $2.38M | ﹤0.01% |
7,157
-15,198
| -68% | -$7.22M |
|
|
RWT
3047
Redwood Trust
RWT
$580M
| $2.38M | ﹤0.01% |
180,158
+103,618
| +135% | +$1.4M |
|
3048
PUT
ICICI Bank
IBN
$107B
| $2.38M | ﹤0.01% |
120,000
| – | – |
|
|
EVBG
3049
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.38M | ﹤0.01% |
35,282
+32,237
| +1,059% | +$3.9M |
|
3050
CALL
Otis Worldwide
OTIS
$27.3B
| $2.37M | ﹤0.01% |
27,200
| – | – |
|
Similar funds
David Shaw's Q4 2021 Portfolio in Review
As of Q4 2021, David Shaw held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $7.58B in Q4 2021, closing 616 positions and reducing 1,595 holdings. Its most notable exit was Aon, an estimated $179M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares Core S&P 500 ETF worth $1.02B.
- David Shaw's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
- David Shaw added most to Sea Limited in Q4 2021, an estimated $480M increase.
- David Shaw's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
- David Shaw fully exited Aon in Q4 2021, selling an estimated $179M.
- David Shaw's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
- David Shaw opened 1,032 new positions and closed 616 in Q4 2021.
- David Shaw's portfolio value rose 8.8% quarter-over-quarter to $121B.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.